Screener
Lexicon Pharmaceuticals LXRX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
The source filing: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026. Open the filing →
- Filed
- Mar 5, 2026, 4:50 PM EST
- Fiscal year
- FY2025
- Accession
- 0001062822-26-000050
FAQ
- What is Lexicon Pharmaceuticals's free cash flow?
- Lexicon Pharmaceuticals (LXRX) reported free cash flow of -$17.23M in Q4 2025.
- How has Lexicon Pharmaceuticals's free cash flow changed year-over-year?
- Lexicon Pharmaceuticals's free cash flow increased by 21.5% year-over-year, from -$21.97M to -$17.23M.
- What is the long-term trend for Lexicon Pharmaceuticals's free cash flow?
- Over 3 years (2021 to 2024), Lexicon Pharmaceuticals's free cash flow has grown at a 26.8% compound annual growth rate (CAGR), from -$88.24M to -$179.81M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Lexicon Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude